Last 12 months
Inside the activity.
1 purchase rows · 78 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 1 | 25 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 20 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 21 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 29, 2024 Filed May 1, 2024 23:59 UTC |
RAAB MICHAELDirector · President & CEO
|
Exercise / conversionCommon Stock | 30,000 | $0.99 | $29,700.00 |
DisclosureSEC source: 0001610717-24-000228 · form4.xml · nonDerivative · entry 1 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,340,933 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 13, 2023. Read SEC document |
| April 15, 2024 Filed Apr 17, 2024 20:20 UTC |
RAAB MICHAELDirector · President & CEO
|
SaleCommon Stock | 7,500 | $7.06 | $52,923.75 |
DisclosureSEC source: 0001610717-24-000211 · form4.xml · nonDerivative · entry 1 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,310,933 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 13, 2023. F2 · price: This transaction was executed in multiple trades in prices ranging from $7.015 to $7.09, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 20:05 UTC |
RAAB MICHAELDirector · President & CEO
|
SaleCommon Stock | 1,518 | $7.31 | $11,096.58 |
DisclosureSEC source: 0001610717-24-000199 · form4.xml · nonDerivative · entry 1 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,318,433 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 13, 2023. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 22:13 UTC |
Kelliher MikeSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 205,000 | $0.00 Strike: $7.70 | $0.00 |
DisclosureSEC source: 0001610717-24-000188 · form4.xml · derivative · entry 2 Kelliher Mike · CIK 0001987188 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 205,000 Underlying: Common Stock · 205,000 shares Expires 2034-03-25 F2 · derivative.exercise_date: Twenty Five Percent (25%) of the shares subject to the option vest on March 25, 2025 and the remaining shares subject to the option vest in 36 successive, equal monthly installments thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 22:13 UTC |
Kelliher MikeSee Remarks
|
GrantCommon Stock | 160,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001610717-24-000188 · form4.xml · nonDerivative · entry 1 Kelliher Mike · CIK 0001987188 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,000 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 20:42 UTC |
GRAMMER ELIZABETH ASee Remarks
|
SaleCommon Stock | 86,000 | $7.73 | $664,977.80 |
DisclosureSEC source: 0001610717-24-000182 · form4.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 312,993 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 20, 2023. F2 · price: This transaction was executed in multiple trades in prices ranging from $7.65 to $7.92, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| March 15, 2024 Filed Mar 22, 2024 18:18 UTC |
Blanks RobertSee Remarks
|
GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001610717-24-000183 · form4.xml · nonDerivative · entry 1 Blanks Robert · CIK 0001815433 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 367,186 Read SEC document |
| February 26, 2024 Filed Feb 28, 2024 23:57 UTC |
Rosenbaum David P.Chief Development Officer
|
SaleCommon Stock | 5,183 | $9.20 | $47,683.60 |
DisclosureSEC source: 0001610717-24-000103 · form4.xml · nonDerivative · entry 1 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Wife Disclosed balance after: 175,936 F1 · ownership.nature: The shares are directly held by the Reporting Person's wife. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 16:56 UTC |
Rodriguez SusanChief Commercial Officer
|
SaleCommon Stock | 6,928 | $8.75 | $60,594.37 |
DisclosureSEC source: 0001610717-24-000082 · form4.xml · nonDerivative · entry 1 Rodriguez Susan · CIK 0001812511 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 452,795 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 21:56 UTC |
Williams Laura AChief Medical Officer
|
SaleCommon Stock | 4,803 | $8.75 | $42,008.48 |
DisclosureSEC source: 0001610717-24-000080 · form4.xml · nonDerivative · entry 1 Williams Laura A · CIK 0001869194 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 380,138 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 16:58 UTC |
Blanks RobertSee Remarks
|
SaleCommon Stock | 5,017 | $8.75 | $43,880.19 |
DisclosureSEC source: 0001610717-24-000084 · form4.xml · nonDerivative · entry 1 Blanks Robert · CIK 0001815433 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 368,186 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 17:01 UTC |
Renz Justin AChief Financial Officer
|
SaleCommon Stock | 5,341 | $8.75 | $46,713.99 |
DisclosureSEC source: 0001610717-24-000087 · form4.xml · nonDerivative · entry 1 Renz Justin A · CIK 0001466562 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 304,835 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 23:30 UTC |
Rosenbaum David P.Chief Development Officer
|
SaleCommon Stock | 2,294 | $8.75 | $20,064.01 |
DisclosureSEC source: 0001610717-24-000089 · form4.xml · nonDerivative · entry 2 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Wife Disclosed balance after: 181,119 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. F2 · ownership.nature: The shares are directly held by the Reporting Person's wife. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 23:30 UTC |
Rosenbaum David P.Chief Development Officer
|
SaleCommon Stock | 5,017 | $8.75 | $43,880.19 |
DisclosureSEC source: 0001610717-24-000089 · form4.xml · nonDerivative · entry 1 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 378,985 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 21:58 UTC |
RAAB MICHAELDirector · President & CEO
|
SaleCommon Stock | 22,917 | $8.75 | $200,438.96 |
DisclosureSEC source: 0001610717-24-000085 · form4.xml · nonDerivative · entry 1 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,319,951 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 21:57 UTC |
GRAMMER ELIZABETH ASee Remarks
|
SaleCommon Stock | 4,432 | $8.75 | $38,763.60 |
DisclosureSEC source: 0001610717-24-000083 · form4.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 398,993 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 21:56 UTC |
Felsch Robert OraSee Remarks
|
SaleCommon Stock | 2,352 | $8.75 | $20,571.30 |
DisclosureSEC source: 0001610717-24-000081 · form4.xml · nonDerivative · entry 1 Felsch Robert Ora · CIK 0001917819 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 184,834 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| February 08, 2024 Filed Feb 9, 2024 21:14 UTC |
Rosenbaum David P.Chief Development Officer
|
SaleCommon Stock | 15,344 | $9.18 | $140,845.64 |
DisclosureSEC source: 0001610717-24-000050 · form4.xml · nonDerivative · entry 1 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 384,002 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 9, 2023. F2 · price: This transaction was executed in multiple trades in prices ranging from $8.97 to $9.49, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 16:37 UTC |
Rodriguez SusanChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 145,000 | $0.00 Strike: $8.78 | $0.00 |
DisclosureSEC source: 0001628280-24-001686 · wk-form4_1705613823.xml · derivative · entry 2 Rodriguez Susan · CIK 0001812511 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,000 Underlying: Common Stock · 145,000 shares Expires 2034-01-16 F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 16, 2024, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 16:37 UTC |
Rodriguez SusanChief Commercial Officer
|
GrantCommon Stock | 112,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-001686 · wk-form4_1705613823.xml · nonDerivative · entry 1 Rodriguez Susan · CIK 0001812511 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 459,723 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 21:39 UTC |
Williams Laura AChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 152,127 | $0.00 Strike: $8.78 | $0.00 |
DisclosureSEC source: 0001628280-24-001692 · wk-form4_1705613951.xml · derivative · entry 2 Williams Laura A · CIK 0001869194 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 152,127 Underlying: Common Stock · 152,127 shares Expires 2034-01-16 F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 16, 2024, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 21:39 UTC |
Williams Laura AChief Medical Officer
|
GrantCommon Stock | 118,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-001692 · wk-form4_1705613951.xml · nonDerivative · entry 1 Williams Laura A · CIK 0001869194 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 384,941 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 16:31 UTC |
Blanks RobertSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 145,000 | $0.00 Strike: $8.78 | $0.00 |
DisclosureSEC source: 0001628280-24-001676 · wk-form4_1705613501.xml · derivative · entry 2 Blanks Robert · CIK 0001815433 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,000 Underlying: Common Stock · 145,000 shares Expires 2034-01-16 F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 16, 2024, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 16:31 UTC |
Blanks RobertSee Remarks
|
GrantCommon Stock | 112,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-001676 · wk-form4_1705613501.xml · nonDerivative · entry 1 Blanks Robert · CIK 0001815433 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 373,203 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 16:36 UTC |
Renz Justin AChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 164,000 | $0.00 Strike: $8.78 | $0.00 |
DisclosureSEC source: 0001628280-24-001684 · wk-form4_1705613767.xml · derivative · entry 2 Renz Justin A · CIK 0001466562 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,000 Underlying: Common Stock · 164,000 shares Expires 2034-01-16 F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 16, 2024, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 16:36 UTC |
Renz Justin AChief Financial Officer
|
GrantCommon Stock | 127,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-001684 · wk-form4_1705613767.xml · nonDerivative · entry 1 Renz Justin A · CIK 0001466562 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 310,176 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 21:38 UTC |
Rosenbaum David P.Chief Development Officer
|
GrantStock Option (Right to Buy) · Derivative | 99,000 | $0.00 Strike: $8.78 | $0.00 |
DisclosureSEC source: 0001628280-24-001689 · wk-form4_1705613880.xml · derivative · entry 5 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Wife Disclosed balance after: 99,000 Underlying: Common Stock · 99,000 shares Expires 2034-01-16 F4 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 16, 2024, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. F2 · ownership.nature: The shares are directly held by the Reporting Person's wife. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 21:38 UTC |
Rosenbaum David P.Chief Development Officer
|
GrantStock Option (Right to Buy) · Derivative | 145,000 | $0.00 Strike: $8.78 | $0.00 |
DisclosureSEC source: 0001628280-24-001689 · wk-form4_1705613880.xml · derivative · entry 4 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,000 Underlying: Common Stock · 145,000 shares Expires 2034-01-16 F4 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 16, 2024, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 21:38 UTC |
Rosenbaum David P.Chief Development Officer
|
GrantCommon Stock | 70,120 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-001689 · wk-form4_1705613880.xml · nonDerivative · entry 2 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Wife Disclosed balance after: 183,413 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. F2 · ownership.nature: The shares are directly held by the Reporting Person's wife. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 21:38 UTC |
Rosenbaum David P.Chief Development Officer
|
GrantCommon Stock | 112,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-001689 · wk-form4_1705613880.xml · nonDerivative · entry 1 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 399,346 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 21:35 UTC |
RAAB MICHAELDirector · President & CEO
|
GrantStock Option (Right to Buy) · Derivative | 605,904 | $0.00 Strike: $8.78 | $0.00 |
DisclosureSEC source: 0001628280-24-001682 · wk-form4_1705613694.xml · derivative · entry 4 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 605,904 Underlying: Common Stock · 605,904 shares Expires 2034-01-16 F4 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 16, 2024, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 21:35 UTC |
RAAB MICHAELDirector · President & CEO
|
GrantCommon Stock | 475,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-001682 · wk-form4_1705613694.xml · nonDerivative · entry 1 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,342,868 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 21:34 UTC |
GRAMMER ELIZABETH ASee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 164,000 | $0.00 Strike: $8.78 | $0.00 |
DisclosureSEC source: 0001628280-24-001680 · wk-form4_1705613639.xml · derivative · entry 2 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,000 Underlying: Common Stock · 164,000 shares Expires 2034-01-16 F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 16, 2024, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 21:34 UTC |
GRAMMER ELIZABETH ASee Remarks
|
GrantCommon Stock | 127,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-001680 · wk-form4_1705613639.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 403,425 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 21:32 UTC |
Felsch Robert OraSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 99,000 | $0.00 Strike: $8.78 | $0.00 |
DisclosureSEC source: 0001628280-24-001678 · wk-form4_1705613557.xml · derivative · entry 2 Felsch Robert Ora · CIK 0001917819 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,000 Underlying: Common Stock · 99,000 shares Expires 2034-01-16 F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 16, 2024, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 21:32 UTC |
Felsch Robert OraSee Remarks
|
GrantCommon Stock | 70,120 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-001678 · wk-form4_1705613557.xml · nonDerivative · entry 1 Felsch Robert Ora · CIK 0001917819 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 187,186 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 22:36 UTC |
Rosenbaum David P.Chief Development Officer
|
SaleCommon Stock | 30,000 | $6.64 | $199,200.00 |
DisclosureSEC source: 0001628280-24-001059 · wk-form4_1704926150.xml · nonDerivative · entry 1 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 286,596 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 9, 2023. F2 · price: This transaction was executed in multiple trades in prices ranging from $6.46 to $7.00, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| December 26, 2023 Filed Dec 28, 2023 17:44 UTC |
Renz Justin AChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $0.99 | $0.00 |
DisclosureSEC source: 0001628280-23-042828 · wk-form4_1703803478.xml · derivative · entry 3 Renz Justin A · CIK 0001466562 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 121,000 Underlying: Common Stock · 75,000 shares Expires 2032-01-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 12, 2023. F3 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| December 26, 2023 Filed Dec 28, 2023 17:44 UTC |
Renz Justin AChief Financial Officer
|
SaleCommon Stock | 225,000 | $6.36 | $1,430,122.50 |
DisclosureSEC source: 0001628280-23-042828 · wk-form4_1703803478.xml · nonDerivative · entry 2 Renz Justin A · CIK 0001466562 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 182,426 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 12, 2023. F2 · price: This transaction was executed in multiple trades in prices ranging from $6.28 to $6.45, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| December 26, 2023 Filed Dec 28, 2023 17:44 UTC |
Renz Justin AChief Financial Officer
|
Exercise / conversionCommon Stock | 75,000 | $0.99 | $74,250.00 |
DisclosureSEC source: 0001628280-23-042828 · wk-form4_1703803478.xml · nonDerivative · entry 1 Renz Justin A · CIK 0001466562 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 407,426 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 12, 2023. Read SEC document |
| December 18, 2023 Filed Dec 20, 2023 21:49 UTC |
Rosenbaum David P.Chief Development Officer
|
SaleCommon Stock | 5,675 | $6.07 | $34,447.25 |
DisclosureSEC source: 0001628280-23-042268 · wk-form4_1703108983.xml · nonDerivative · entry 1 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 316,596 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 9, 2023. Read SEC document |
| December 14, 2023 Filed Dec 15, 2023 23:13 UTC |
Rosenbaum David P.Chief Development Officer
|
SaleCommon Stock | 7,000 | $5.55 | $38,850.00 |
DisclosureSEC source: 0001628280-23-041699 · wk-form4_1702682026.xml · nonDerivative · entry 1 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 322,271 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 9, 2023. Read SEC document |
| December 11, 2023 Filed Dec 13, 2023 22:44 UTC |
GRAMMER ELIZABETH ASee Remarks
|
SaleCommon Stock | 50,000 | $5.08 | $253,925.00 |
DisclosureSEC source: 0001628280-23-041479 · wk-form4_1702507443.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 275,675 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 24, 2023. F2 · price: This transaction was executed in multiple trades in prices ranging from $4.99 to $5.27, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| December 08, 2023 Filed Dec 8, 2023 22:58 UTC |
Rosenbaum David P.Chief Development Officer
|
SaleCommon Stock | 20,000 | $5.27 | $105,476.00 |
DisclosureSEC source: 0001628280-23-041167 · wk-form4_1702076302.xml · nonDerivative · entry 1 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 329,271 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 9, 2023. F2 · price: This transaction was executed in multiple trades in prices ranging from $5.18 to $5.32, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| December 05, 2023 Filed Dec 6, 2023 21:49 UTC |
Rosenbaum David P.Chief Development Officer
|
SaleCommon Stock | 10,272 | $5.00 | $51,360.00 |
DisclosureSEC source: 0001628280-23-040906 · wk-form4_1701899354.xml · nonDerivative · entry 1 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 349,271 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 9, 2023. Read SEC document |
| November 30, 2023 Filed Dec 1, 2023 21:47 UTC |
Rosenbaum David P.Chief Development Officer
|
SaleCommon Stock | 3,000 | $4.50 | $13,500.00 |
DisclosureSEC source: 0001628280-23-040465 · wk-form4_1701467244.xml · nonDerivative · entry 1 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 359,543 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 9, 2023. Read SEC document |
| November 20, 2023 Filed Nov 22, 2023 17:20 UTC |
Rodriguez SusanChief Commercial Officer
|
SaleCommon Stock | 4,714 | $4.36 | $20,563.41 |
DisclosureSEC source: 0001628280-23-039904 · wk-form4_1700691637.xml · nonDerivative · entry 1 Rodriguez Susan · CIK 0001812511 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 346,973 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. F2 · balance_after: Reflects the adjusted total which includes the purchase of 3,000 shares under the Ardelyx Employee Stock Purchase Plan in August 2023. Read SEC document |
| November 20, 2023 Filed Nov 22, 2023 22:22 UTC |
Williams Laura AChief Medical Officer
|
SaleCommon Stock | 2,581 | $4.36 | $11,258.84 |
DisclosureSEC source: 0001628280-23-039907 · wk-form4_1700691709.xml · nonDerivative · entry 1 Williams Laura A · CIK 0001869194 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 266,191 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. F2 · balance_after: Reflects the adjusted total which includes the purchase of 1,933 shares under the Ardelyx Employee Stock Purchase Plan in August 2023. Read SEC document |
| November 20, 2023 Filed Nov 22, 2023 17:17 UTC |
Blanks RobertSee Remarks
|
SaleCommon Stock | 2,835 | $4.36 | $12,366.84 |
DisclosureSEC source: 0001628280-23-039897 · wk-form4_1700691463.xml · nonDerivative · entry 1 Blanks Robert · CIK 0001815433 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 260,453 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| November 20, 2023 Filed Nov 22, 2023 17:20 UTC |
Renz Justin AChief Financial Officer
|
SaleCommon Stock | 2,873 | $4.36 | $12,532.60 |
DisclosureSEC source: 0001628280-23-039902 · wk-form4_1700691607.xml · nonDerivative · entry 1 Renz Justin A · CIK 0001466562 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 332,426 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. F2 · balance_after: Reflects the adjusted total which includes the purchase of 1,450 shares under the Ardelyx Employee Stock Purchase Plan in August 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.